TNP-470 combined with nicardipine suppresses in vivo growth of PC-3, a human prostate cancer cell line

被引:6
|
作者
Arisawa, C [1 ]
Kageyama, Y [1 ]
Kawakami, S [1 ]
Kihara, K [1 ]
机构
[1] Tokyo Med & Dent Univ, Grad Sch, Dept Urol & Reprod Med, Bunkyo Ku, Tokyo 1138519, Japan
来源
UROLOGIC ONCOLOGY | 2002年 / 7卷 / 06期
关键词
angiogenesis; inhibitor; prostate; neoplasm;
D O I
10.1016/S1078-1439(02)00195-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We examined effects of TNP-470 with or without nicardipine on in vivo or in vitro growth of a hormone-independent human prostate carcinoma cell line, PC-3. TNP-470 (30 mg/kg, daily) or nicardipine (25 mug/kg, daily) alone had little effects on in vivo growth of PC-3 cells in Dude mice, whereas simultaneous administration of both agents significantly inhibited the growth of the xenografts. In vitro proliferarion of PC-3 was not affected by TNP-470 and/or nicardipin. Combination of TNP-470 and nicardipine seems beneficial in the treatment of hormone-refractory prostate cancer. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 50 条
  • [31] Combined treatment with TNP-470 and 5-fluorouracil effectively inhibits growth of murine colon cancer cells in vitro and liver metastasis in vivo
    Ogawa, H
    Sato, Y
    Kondo, M
    Takahashi, N
    Oshima, T
    Sasaki, F
    Une, Y
    Nishihira, J
    Todo, S
    ONCOLOGY REPORTS, 2000, 7 (03) : 467 - 472
  • [32] Bortezomib and etoposide combinations exert synergistic effects on the human prostate cancer cell line PC-3
    Aras, Bekir
    Yerlikaya, Azmi
    ONCOLOGY LETTERS, 2016, 11 (05) : 3179 - 3184
  • [33] Regulatory roles of KDR antisense oligonucleotide on the proliferation of human prostate cancer cell line PC-3
    Song, Jianghong
    Song, Yisheng
    Guo, Wei
    Jia, Junqi
    Jin, Yongsheng
    Bai, Ansheng
    JOURNAL OF BUON, 2014, 19 (03): : 770 - 774
  • [34] Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model
    Muramaki, M
    Miyake, H
    Hara, I
    Kawabata, G
    Kamidono, S
    JOURNAL OF UROLOGY, 2004, 172 (04): : 1485 - 1489
  • [35] Reduction of oxidative stress and ornithine decarboxylase expression in a human prostate cancer cell line PC-3 by a combined treatment with α-tocopherol and naringenin
    Torricelli, Piera
    Elia, Antonia Concetta
    Magara, Gabriele
    Feriotto, Giordana
    Forni, Cinzia
    Borromeo, Ilaria
    De Martino, Angelo
    Tabolacci, Claudio
    Mischiati, Carlo
    Beninati, Simone
    AMINO ACIDS, 2021, 53 (01) : 63 - 72
  • [36] Reduction of oxidative stress and ornithine decarboxylase expression in a human prostate cancer cell line PC-3 by a combined treatment with α-tocopherol and naringenin
    Piera Torricelli
    Antonia Concetta Elia
    Gabriele Magara
    Giordana Feriotto
    Cinzia Forni
    Ilaria Borromeo
    Angelo De Martino
    Claudio Tabolacci
    Carlo Mischiati
    Simone Beninati
    Amino Acids, 2021, 53 : 63 - 72
  • [37] CCL2 INCREASES IN VIVO TUMOR GROWTH OF HUMAN PROSTATE CANCER PC-3 TUMOR XENOGRAFT
    Mizutani, Kosuke
    Sud, Sudha
    Varsos, Zachary
    Roca, Hernan
    Pienta, Kenneth J.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 264 - 264
  • [38] In vitro and in vivo (SCID mice) effects of phytosterols on the growth and dissemination of human prostate cancer PC-3 cells
    Awad, AB
    Fink, CS
    Williams, H
    Kim, U
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2001, 10 (06) : 507 - 513
  • [39] Angiogenesis inhibitor TNP-470 inhibits growth and metastasis of a hormone-independent rat prostatic carcinoma cell line
    Miki, T
    Nonomura, N
    Nozawa, M
    Harada, Y
    Nishimura, K
    Kojima, Y
    Takahara, S
    Okuyama, A
    JOURNAL OF UROLOGY, 1998, 160 (01): : 210 - 213
  • [40] Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo
    Srivastava, SK
    Xiao, D
    Lew, KL
    Hershberger, P
    Kokkinakis, DM
    Johnson, CS
    Trump, DL
    Singh, SV
    CARCINOGENESIS, 2003, 24 (10) : 1665 - 1670